Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_001032373.2(ZNF226):c.37G>T(p.Val13Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V13M) has been classified as Uncertain significance.
ZNF226 (HGNC:13019): (zinc finger protein 226) Predicted to enable DNA-binding transcription activator activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Gain of ubiquitination at K11 (P = 0.1586);Gain of ubiquitination at K11 (P = 0.1586);Gain of ubiquitination at K11 (P = 0.1586);Gain of ubiquitination at K11 (P = 0.1586);Gain of ubiquitination at K11 (P = 0.1586);Gain of ubiquitination at K11 (P = 0.1586);Gain of ubiquitination at K11 (P = 0.1586);Gain of ubiquitination at K11 (P = 0.1586);Gain of ubiquitination at K11 (P = 0.1586);Gain of ubiquitination at K11 (P = 0.1586);Gain of ubiquitination at K11 (P = 0.1586);Gain of ubiquitination at K11 (P = 0.1586);Gain of ubiquitination at K11 (P = 0.1586);Gain of ubiquitination at K11 (P = 0.1586);Gain of ubiquitination at K11 (P = 0.1586);Gain of ubiquitination at K11 (P = 0.1586);Gain of ubiquitination at K11 (P = 0.1586);